Pharmaceutical Strategies Group Revenue and Competitors

Dallas, TX USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Pharmaceutical Strategies Group's estimated annual revenue is currently $57.9M per year.(i)
  • Pharmaceutical Strategies Group's estimated revenue per employee is $201,000

Employee Data

  • Pharmaceutical Strategies Group has 288 Employees.(i)
  • Pharmaceutical Strategies Group grew their employee count by -2% last year.

Pharmaceutical Strategies Group's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Product Owner & Implementation SpecialistReveal Email/Phone
3
CEOReveal Email/Phone
4
VP, Health Plan ConsultingReveal Email/Phone
5
VP, Plan Sponsor ConsultingReveal Email/Phone
6
SVP, Plan SponsorsReveal Email/Phone
7
SVP & Practice Lead, Health Plans at Pharmaceutical Strategies Group-PSGReveal Email/Phone
8
VP, PBM Implementation ProjectsReveal Email/Phone
9
VP FinanceReveal Email/Phone
10
SVP, Business DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$26.7M13320%N/AN/A
#2
$13.5M676%N/AN/A
#3
$16.1M80-2%N/AN/A
#4
$62.5M0N/AN/AN/A
#5
$10.1M506%N/AN/A
#6
$119.4M59427%N/AN/A
#7
$22.9M1148%N/AN/A
#8
$92.9M4628%N/AN/A
#9
$11.3M56-8%N/AN/A
#10
$7M356%N/AN/A
Add Company

What Is Pharmaceutical Strategies Group?

Pharmaceutical Strategies Group (PSG), based in Plano, Texas, is the largest independent pharmacy program consulting firm in the U.S. PSG designs and implements custom and creative pharmacy benefit management, clinical and supply chain solutions that allow clients to greatly maximize the value of pharmaceuticals across their operations. PSG generated more than $2 billion in cost savings for its 300-plus clients, representing improved outcomes to 100 million lives in the last two years. The 21-year-old company’s clients include health plans, hospitals and health systems, labor unions, coalitions and self-insured employers.

keywords:N/A

N/A

Total Funding

288

Number of Employees

$57.9M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Pharmaceutical Strategies Group News

2022-04-20 - Global Dexlansoprazole Market 2022 Business Strategies ...

Global Dexlansoprazole Market 2022 Business Strategies – Takeda, Cardinal Health ... Suzhou Homesun Pharmaceutical; Frontida; Zhendong Group...

2022-04-06 - Sanofi's CDMO spinoff set for next month as new group targets ...

Karl Rotthier, former CEO of Dutch drugmaker Centrient Pharmaceuticals, ... So far, the strategy seems to be working: Sanofi just this week increased its...

2022-03-30 - pharmaceutical detailing

Both of these newer strategies have led to a reduction in the sales force of pharma companies. With its biased nature and restrictions in the U.S., these newer...

2021-03-04 - Pharmaceutical Strategies Group Unveils Solution to Double Drug Cost Savings

DALLAS--(BUSINESS WIRE)--Mar 4, 2021-- Pharmaceutical Strategies Group (PSG), an EPIC company, is innovating in the drug management space again with the launch of its PSG Complete solution. The PSG Complete process safeguards client drug spend through continual oversight. This press release fe ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$55.8M2902%N/A
#2
$35M2919%N/A
#3
$45.5M2925%$22.4M
#4
$55.5M29539%$40M
#5
$45.6M296-5%N/A